VTR Stock Analysis — Ventas Inc.
Sector: Healthcare REIT
AI Verdict
You're paying a premium the numbers don't yet support—at 105.4x forward earnings, even rapid EPS growth needs to materialize fast to avoid a painful correction, though the moat in healthcare real estate is real.
Competitive Moat
Ventas owns and operates a diversified portfolio of senior housing and healthcare properties, benefiting from long-term demographic trends and high barriers to entry due to regulatory complexity and capital requirements. Its scale and established operator relationships give it pricing power and stable tenant demand.
Summary
Ventas is notable for its rare combination of a 33.70% 1-year return and an RSI of 30.0, signaling technical oversold conditions despite strong recent gains.
Where It Stands
The stock is up 33.70% over the past year, trades at 105.4x next year's earnings versus a healthcare sector median of 22x, and its RSI of 30.0 suggests it is technically oversold.
Key Metrics
- RSI: 30 — Near Oversold
- Trailing P/E: 165.7x
- Forward P/E: 105.4x
- PEG Ratio: 3.11
- Earnings Growth: +0.6%
- Revenue Growth: +0.2%
- Market Cap: $46.3B
- Dividend Yield: 0.02%
- 1-Year Return: 33.70%
- 52-Week High: $101.60
- 52-Week Low: $66.38
Analyst Consensus
22 Buy · 5 Hold · 0 Sell (27 analysts)
Bull Case
Analysts expect forward EPS growth of 57.1%, which could justify the high 105.4x forward P/E if Ventas delivers on its operational turnaround.
Bear Case
If the P/E multiple compresses to the sector median of 22x, the stock would lose nearly 80% of its value from current earnings levels.
Catalyst to Watch
Watch for quarterly earnings results to confirm that the forecasted 57.1% EPS growth is materializing, as any miss could trigger a sharp valuation reset.